Skip to main content

stock

NVNO · enVVeno Medical Corp

What enVVeno Medical Corp reports to the SEC, read from its filings.

Open in the app

Price

The live NVNO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on NVNO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
682,722 as of 2026-07-28 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-76.1%
ROA
-69.4%

Health

Current ratio
11.7x
Debt/equity
—

Deep value

NCAV
$20.09M
NCAV per share
$29.43
Price/NCAV
Locked
NNWC
$851,000
NNWC per share
$1.25
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$3.80M-$3.60M
10-Q filed 2026-07-30
2026-03-31——-$4.06M-$3.85M
10-Q filed 2026-05-06
2025-12-31——-$4.01M-$3.74M
10-K filed 2026-03-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——-$4.88M-$4.54M
10-Q filed 2025-10-30
2025-06-30——-$7.05M-$6.69M
10-Q filed 2026-07-30
2025-03-31——-$4.95M-$4.50M
10-Q filed 2026-05-06
2024-12-31——-$6.70M-$6.23M
10-K filed 2026-03-26
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$6.17M-$5.64M
10-Q filed 2025-10-30
Assets
$22.66M
Equity
$20.67M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$20.90M-$19.47M-$15.57M
2024-12-31—-$23.83M-$21.82M-$16.88M
2023-12-31—-$25.24M-$23.52M-$18.89M
2022-12-31—-$24.93M-$24.67M-$15.73M
2021-12-31—-$16.89M-$16.53M-$12.22M
2020-12-31—-$9.14M-$9.14M-$7.86M
2019-12-31$31,243-$7.68M-$7.63M-$6.26M
2018-12-31$186,552-$7.85M-$13.04M-$6.37M
2017-12-31$422,111-$6.10M-$7.79M-$4.21M

Company filings

since Fri Aug 21 · 1 offering filing in 12 months · since Thu Oct 30

events

  • Regulation FD disclosure

    Regulation FD disclosure
    Jul 148-K
  • Results, Regulation FD disclosure, Other event

    ResultsRegulation FD disclosureOther event
    Apr 298-K
  • Results, Other event

    ResultsOther event
    Feb 48-K
  • Bylaws or fiscal year change

    Bylaws or fiscal year change
    Jan 208-K
  • Shareholder vote results

    Shareholder vote results
    Dec 128-K
  • Bylaws or fiscal year change

    Bylaws or fiscal year change
    11/20/20258-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Duhay Francis

    Director

    Sale$123

    Sep 14, 6:56 PM ET

All insider trades for NVNO

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named NVNO, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about NVNO.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about NVNO.

nakagai

Signals on NVNO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the NVNO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

enVVeno Medical Corp (NVNO): SEC filings, financials and insider trades · Nakagai